Cerebello-motor Neuromodulation After Stroke. CERSTIM.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-13

Study Completion Date

2027-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The CERSTIM study is a physiopatholgical study investigating transcranial alternating current stimulation in stroke patients in the cerebello-motor loop.

The design is a cross over design testing two frequencies in the gamma band and one placebo.

We will use behavioural data, functional MRI, and Electroencephalography to disentangle the effect of tACS and its frequency.

Healthy participants will be also recruited.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation

NCT02052271

Essential Tremor

COMPLETED NA

Early Neuromodulation in Traumatic Brain Injury

NCT06871124

Traumatic Brain Injury (TBI) Patients

RECRUITING NA

Effects of Different Intensities of Bilateral-transcranial Direct Current Stimulation in Healthy Individuals

NCT05929014

Healthy

COMPLETED NA

Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis

NCT02266121

Relapsing Remitting Multiple Sclerosis Secondary-progressive Multiple Sclerosis Cognitive Deficits +1 more

TERMINATED NA

Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

NCT04653012

Focal Epilepsy Electrodes, Implanted Cognitive Function +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neuromodulation, by the means of Non-Invasive Brain Stimulation techniques, is a promising method to enhance motor recovery of the upper limb following a stroke. However, none of these techniques have yet been effectively transferred to the patient's bedside. An international group of experts has examined this issue, identifying barriers that need to be overcome for successful transferability. Among their findings, two were particularly emphasized: (i) the insufficient characterization of the mechanisms through which these stimulations are effective, and (ii) the comparison of stimulation parameters before moving on to larger samples. We have decided to use this model to study tACS (transcranial Alternating Current Stimulation) on the cerebellomotor network.

The choice of tACS is justified by (i) its ability to "entrain" a neural network through its oscillations, (ii) its innovative nature, and (iii) its "wearable" characteristic, making it quickly transferable. The choice of the cerebellomotor network is based on literature data showing that (i) the cerebellum plays a crucial role in motor learning in healthy individuals (which is one of the substrates of post-stroke recovery), and (ii) cerebellomotor synchronization is a good prognostic indicator for the recovery of hand motor function.

In light of these findings, we have decided to conduct a pathophysiological, bi-centric study to determine the cerebral mechanisms by which tACS acts on the cerebellomotor network. Three single sessions of tACS, each lasting 20 minutes, will be conducted 7-15 days apart, with a different frequency (50 or 70 Hz, corresponding to gamma oscillations) or a placebo frequency known as "sham." To understand the cerebral mechanisms, we will use Magnetic Resonance Imaging (MRI) and Electroencephalography (EEG). We will also examine a behavioral motor adaptation task on a tablet. The order in which the three frequencies are applied will be randomized This study will include 30 patients and 15 healthy subjects. The patients will be individuals who have suffered a stroke more than 6 months ago, resulting in a hand deficit without complete paralysis. The healthy controls will serve as a reference for mechanisms and imaging/electrophysiology data.

We hypothesize the following: The mechanisms involved following cerebellomotor stimulation could include a modification of brain rhythms in the beta or gamma band during movement, an increase in activity in the primary motor cortex, or a change in the excitation-inhibition balance between the cerebellum and the primary motor cortex, or directly at the level of the primary motor cortex. These different mechanisms may vary depending on the frequency used.

This research is part of the NEUROTECH Impulse Program managed by INSERM.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Three sessions active tACS 20 minutes, 50Htz active tACS 20 minutes, 70 Htz sham

Order will be randomized

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Participants are blinded from the type of intervention (sham, 50 Htz or 70 Htz)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tACS session 50 Hz

Three single sessions of tACS, each lasting 20 minutes, will be conducted 7-15 days apart, with a different frequency (50 or 70 Hz, corresponding to gamma oscillations) or a placebo frequency known as "sham."

Group Type ACTIVE_COMPARATOR

tACS Transcranial alternating stimulation

Intervention Type DEVICE

session of 20 minutes

tACS session 70 Hz

Three single sessions of tACS, each lasting 20 minutes, will be conducted 7-15 days apart, with a different frequency (50 or 70 Hz, corresponding to gamma oscillations) or a placebo frequency known as "sham."

Group Type ACTIVE_COMPARATOR

tACS Transcranial alternating stimulation

Intervention Type DEVICE

session of 20 minutes

tACS Sham session

Three single sessions of tACS, each lasting 20 minutes, will be conducted 7-15 days apart, with a different frequency (50 or 70 Hz, corresponding to gamma oscillations) or a placebo frequency known as "sham."

Group Type SHAM_COMPARATOR

tACS Transcranial alternating stimulation

Intervention Type DEVICE

session of 20 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tACS Transcranial alternating stimulation

session of 20 minutes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female aged 18 years or older on the day of inclusion.
* Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.
* Ischemic stroke or intraparenchymal hematoma that occurred more than 6 months ago, with no upper time limit.
* Motor deficit of the upper limb confirmed by the ARAT scale, with the ability to grip and press on a tablet.
* stroke lesion not affecting the motor cortex in the hand knob area.

* Male or female aged 18 years or older on the day of inclusion.
* Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.

\-- Pregnant and breastfeeding women

* Conditions that are life-threatening or could compromise follow-up during the study period
* Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
* Participation in another biomedical study during the same period, or current exclusion period from another biomedical study

Exclusion Criteria

\-- Pregnant and breastfeeding women

* Total paralysis of the affected hand
* Conditions that are life-threatening or could compromise follow-up during the study period
* Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
* Participation in another biomedical study focused on motor or overall recovery during the same period, or current exclusion period from another biomedical study

HEALTHY

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes